TP10: Began an open-label, single dose Phase IIa trial

T Cell Sciences Inc. (TCEL), Needham, Mass. Product: TP10, soluble complement receptor 1 Indication: Adult respiratory distress syndrome (ARDS) Status: Began an open-label, single dose Phase IIa tria...